Connection
Bradley Warady to Kidney Transplantation
This is a "connection" page, showing publications Bradley Warady has written about Kidney Transplantation.
|
|
Connection Strength |
|
|
|
|
|
11.370 |
|
|
|
-
Johnson RJ, Warady BA. Does kidney transplant improve health-related quality of life for youth with chronic kidney disease? Kidney Int. 2023 02; 103(2):256-258.
Score: 0.843
-
Odum JD, Kats A, VanSickle JS, Chadha V, Brewer B, Staggs VS, Warady BA. Characterizing the frequency of modifiable histological changes observed on surveillance biopsies in pediatric kidney allograft recipients. Pediatr Nephrol. 2020 11; 35(11):2173-2182.
Score: 0.703
-
Bryan CF, Chadha V, Warady BA. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm. Pediatr Transplant. 2016 Nov; 20(7):926-930.
Score: 0.536
-
Carey WA, Martz KL, Warady BA. Outcome of Patients Initiating Chronic Peritoneal Dialysis During the First Year of Life. Pediatrics. 2015 Sep; 136(3):e615-22.
Score: 0.504
-
Lantos JD, Warady BA. Should a nonadherent adolescent receive a second kidney? Virtual Mentor. 2012 Mar 01; 14(3):190-3.
Score: 0.395
-
Hamilton MS, Singh V, Warady BA. Additional case of acute cellular kidney rejection associated with the presence of antibodies to the red blood cell Kidd antigen. Pediatr Transplant. 2008 Dec; 12(8):918-9.
Score: 0.304
-
Hamilton MS, Singh V, Warady BA. Plasma cell-rich acute cellular rejection of a transplanted kidney associated with antibody to the red cell Kidd antigen. Pediatr Transplant. 2006 Dec; 10(8):974-7.
Score: 0.275
-
Srivastava T, Garola RE, Kestila M, Tryggvason K, Ruotsalainen V, Sharma M, Savin VJ, Jalanko H, Warady BA. Recurrence of proteinuria following renal transplantation in congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol. 2006 May; 21(5):711-8.
Score: 0.261
-
Bryan CF, Winklhofer FT, Murillo D, Ross G, Nelson PW, Shield CF, Warady BA. Improving access to kidney transplantation without decreasing graft survival: long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients. Transplantation. 2005 Jul 15; 80(1):75-80.
Score: 0.250
-
Raina R, Jothi S, Haffner D, Somers M, Filler G, Vasistha P, Chakraborty R, Shapiro R, Randhawa PS, Parekh R, Licht C, Bunchman T, Sethi S, Mangat G, Zaritsky J, Schaefer F, Warady B, Bartosh S, McCulloch M, Alhasan K, Swiatecka-Urban A, Smoyer WE, Chandraker A, Yap HK, Jha V, Bagga A, Radhakrishnan J. Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements. Kidney Int. 2024 Mar; 105(3):450-463.
Score: 0.224
-
Hogan J, Divard G, Aubert O, Garro R, Boyer O, Donald Cooper LA, Farris AB, Fila M, Seifert M, Sellier-Leclerc AL, Smith J, Fichtner A, T?nshoff B, Twombley K, Warady B, Pearl M, Zahr RS, Lefaucheur C, Patzer R, Loupy A. Validation of a prediction system for risk of kidney allograft failure in pediatric kidney transplant recipients: An international observational study. Am J Transplant. 2023 10; 23(10):1561-1569.
Score: 0.217
-
Bae S, Schwartz GJ, Mendley SR, Warady BA, Furth SL, Mu?oz A. Trajectories of eGFR after kidney transplantation according to trajectories of eGFR prior to kidney replacement therapies in children with chronic kidney disease. Pediatr Nephrol. 2023 12; 38(12):4157-4164.
Score: 0.216
-
Yoo D, Goutaudier V, Divard G, Gueguen J, Astor BC, Aubert O, Raynaud M, Demir Z, Hogan J, Weng P, Smith J, Garro R, Warady BA, Zahr RS, Sablik M, Twombley K, Couzi L, Berney T, Boyer O, Duong-Van-Huyen JP, Giral M, Alsadi A, Gourraud PA, Morelon E, Le Quintrec M, Brouard S, Legendre C, Anglicheau D, Villard J, Zhong W, Kamar N, Bestard O, Djamali A, Budde K, Haas M, Lefaucheur C, Rabant M, Loupy A. An automated histological classification system for precision diagnostics of kidney allografts. Nat Med. 2023 05; 29(5):1211-1220.
Score: 0.214
-
Amaral S, McCulloch CE, Lin F, Grimes BA, Furth S, Warady B, Brunson C, Siyahian S, Ku E. Association Between Dialysis Facility Ownership and Access to the Waiting List and Transplant in Pediatric Patients With End-stage Kidney Disease in the US. JAMA. 2022 08 02; 328(5):451-459.
Score: 0.204
-
Warady BA. Neurodevelopment of infants with end-stage renal disease: is it improving? Pediatr Transplant. 2002 Feb; 6(1):5-7.
Score: 0.197
-
Singh NS, Pagano AL, Hays AJ, Kats A, Dahl SM, Warady BA, Beins NT, Yin DE. Ehrlichia-induced hemophagocytic lymphohistiocytosis in a pediatric kidney transplant recipient. Pediatr Transplant. 2022 Feb; 26(1):e14134.
Score: 0.192
-
Wasik H, Chadha V, Galbiati S, Warady B, Atkinson M. Dialysis Outcomes for Children With Lupus Nephritis Compared to Children With Other Forms of Nephritis: A Retrospective Cohort Study. Am J Kidney Dis. 2022 05; 79(5):626-634.
Score: 0.191
-
Shen Q, Fang X, Man X, Zhai Y, Liu L, Wang C, Shang W, Feng G, Zhang L, Zeng L, Zhu Y, Chen J, Rao J, Warady BA, Schaefer F, Xu H. Pediatric kidney transplantation in China: an analysis from the IPNA Global Kidney Replacement Therapy Registry. Pediatr Nephrol. 2021 03; 36(3):685-692.
Score: 0.179
-
Seifert ME, Dahale DS, Kamel M, Winterberg PD, Barletta GM, Belsha CW, Chaudhuri A, Flynn JT, Garro R, George RP, Goebel JW, Kershaw DB, Matossian D, Misurac J, Nailescu C, Nguyen CR, Pearl M, Pollack A, Pruette CS, Singer P, VanSickle JS, Verghese P, Warady BA, Warmin A, Weng PL, Wickman L, Wilson AC, Hooper DK. The Improving Renal Outcomes Collaborative: Blood Pressure Measurement in Transplant Recipients. Pediatrics. 2020 07; 146(1).
Score: 0.175
-
Weidemann DK, Abraham AG, Roem JL, Furth SL, Warady BA. Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) and CKD Progression in Children. Am J Kidney Dis. 2020 08; 76(2):194-202.
Score: 0.171
-
Atkinson MA, Roem JL, Gajjar A, Warady BA, Furth SL, Mu?oz A. Mode of initial renal replacement therapy and transplant outcomes in the chronic kidney disease in children (CKiD) study. Pediatr Nephrol. 2020 06; 35(6):1015-1021.
Score: 0.169
-
Srivastava T, Zwick DL, Rothberg PG, Warady BA. Posttransplant lymphoproliferative disorder in pediatric renal transplantation. Pediatr Nephrol. 1999 Nov; 13(9):748-54.
Score: 0.168
-
Schurman SJ, Stablein DM, Perlman SA, Warady BA. Center volume effects in pediatric renal transplantation. A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol. 1999 Jun; 13(5):373-8.
Score: 0.163
-
Li Y, Greenbaum LA, Warady BA, Furth SL, Ng DK. Short stature in advanced pediatric CKD is associated with faster time to reduced kidney function after transplant. Pediatr Nephrol. 2019 05; 34(5):897-905.
Score: 0.159
-
Warady BA, Sullivan EK. Renal transplantation in children with sickle cell disease: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant. 1998 May; 2(2):130-3.
Score: 0.152
-
Osorio AV, Sullivan EK, Alexander SR, Bryan CF, Shield CF, Warady BA. ABO-mismatched renal transplantation in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) and the Midwest Organ Bank (MOB). Pediatr Transplant. 1998 Feb; 2(1):26-9.
Score: 0.149
-
Hamdani G, Nehus EJ, Hanevold CD, VanSickle JS, Hooper DK, Blowey D, Warady BA, Mitsnefes MM. Ambulatory Blood Pressure Control in Children and Young Adults After Kidney Transplantation. Am J Hypertens. 2017 Oct 01; 30(10):1039-1046.
Score: 0.146
-
Warady BA, H?bert D, Sullivan EK, Alexander SR, Tejani A. Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol. 1997 Feb; 11(1):49-64.
Score: 0.139
-
Hamdani G, Nehus EJ, Hanevold CD, Sebestyen Van Sickle J, Woroniecki R, Wenderfer SE, Hooper DK, Blowey D, Wilson A, Warady BA, Mitsnefes MM. Ambulatory Blood Pressure, Left Ventricular Hypertrophy, and Allograft Function in Children and Young Adults After Kidney Transplantation. Transplantation. 2017 Jan; 101(1):150-156.
Score: 0.138
-
Warady BA, Mudge C, Wiser B, Wiser M, Rader B. Transplant allograft loss in the adolescent patient. Adv Ren Replace Ther. 1996 Apr; 3(2):154-65.
Score: 0.131
-
Bertram JF, Goldstein SL, Pape L, Schaefer F, Shroff RC, Warady BA. Kidney disease in children: latest advances and remaining challenges. Nat Rev Nephrol. 2016 Mar; 12(3):182-91.
Score: 0.130
-
Neu AM, Warady BA. Dialysis and renal transplantation in infants with irreversible renal failure. Adv Ren Replace Ther. 1996 Jan; 3(1):48-59.
Score: 0.129
-
Trachtman H, Frymoyer A, Lewandowski A, Greenbaum LA, Feig DI, Gipson DS, Warady BA, Goebel JW, Schwartz GJ, Lewis K, Anand R, Patel UD. Pharmacokinetics, Pharmacodynamics, and Safety of Lisinopril in Pediatric Kidney Transplant Patients: Implications for Starting Dose Selection. Clin Pharmacol Ther. 2015 Jul; 98(1):25-33.
Score: 0.123
-
Lalan S, Abdel-Rahman S, Gaedigk A, Leeder JS, Warady BA, Dai H, Blowey D. Effect of CYP3A5 genotype, steroids, and azoles on tacrolimus in a pediatric renal transplant population. Pediatr Nephrol. 2014 Oct; 29(10):2039-49.
Score: 0.115
-
Warady BA, Neu AM, Schaefer F. Optimal care of the infant, child, and adolescent on dialysis: 2014 update. Am J Kidney Dis. 2014 Jul; 64(1):128-42.
Score: 0.114
-
Helling TS, Nelson PW, Reed L, Alon U, Hellerstein S, Warady BA. A seven year experience with kidney transplantation for pediatric end stage renal disease. Mo Med. 1994 Jan; 91(1):33-7.
Score: 0.112
-
Bryan CF, Harrell K, Aeder MI, Luger AM, Nelson PW, Pierce GE, Ross G, Shield CF, Warady BA. Impact of HLA DR typing by polymerase chain reaction amplification with DR beta 1 sequence-specific primers on cadaveric renal allocation. Transplant Proc. 1993 Dec; 25(6):3060-3.
Score: 0.112
-
Bryan CF, Aeder MI, Luger AM, Nelson PW, Pierce GE, Ross G, Shield CF, Warady BA. Incidence of a positive final antiglobulin (AHG) T-cell crossmatch in patients waiting for cadaveric renal transplantation is not influenced by race of recipient. Transplant Proc. 1993 Dec; 25(6):3273-4.
Score: 0.112
-
Brown T, Bowman LC, Hellerstein S, Alon U, Warady BA. Neuroblastoma in a renal transplanted child. Pediatr Nephrol. 1993 Aug; 7(4):446-8.
Score: 0.109
-
Johnson RJ, Warady BA. Long-term neurocognitive outcomes of patients with end-stage renal disease during infancy. Pediatr Nephrol. 2013 Aug; 28(8):1283-91.
Score: 0.107
-
Chaudhuri A, Ozawa M, Everly MJ, Ettenger R, Dharnidharka V, Benfield M, Mathias R, Portale A, McDonald R, Harmon W, Kershaw D, Vehaskari VM, Kamil E, Baluarte HJ, Warady B, Li L, Sigdel TK, Hsieh SC, Dai H, Naesens M, Waskerwitz J, Salvatierra O, Terasaki PI, Sarwal MM. The clinical impact of humoral immunity in pediatric renal transplantation. J Am Soc Nephrol. 2013 Mar; 24(4):655-64.
Score: 0.106
-
Bryan CF, Aeder MI, Helling TS, Hughes J, Luger AM, Nelson PW, Pierce GE, Shield CF, Warady B. Influence of HLA and race on long-term cadaveric renal transplantation. Transplant Proc. 1992 Dec; 24(6):2451-3.
Score: 0.104
-
Schwartz ID, Warady BA. Cadaveric renal allograft rejection after treatment with recombinant human growth hormone. J Pediatr. 1992 Oct; 121(4):664-6.
Score: 0.103
-
Li L, Khatri P, Sigdel TK, Tran T, Ying L, Vitalone MJ, Chen A, Hsieh S, Dai H, Zhang M, Naesens M, Zarkhin V, Sansanwal P, Chen R, Mindrinos M, Xiao W, Benfield M, Ettenger RB, Dharnidharka V, Mathias R, Portale A, McDonald R, Harmon W, Kershaw D, Vehaskari VM, Kamil E, Baluarte HJ, Warady B, Davis R, Butte AJ, Salvatierra O, Sarwal MM. A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant. 2012 Oct; 12(10):2710-8.
Score: 0.103
-
Sarwal MM, Ettenger RB, Dharnidharka V, Benfield M, Mathias R, Portale A, McDonald R, Harmon W, Kershaw D, Vehaskari VM, Kamil E, Baluarte HJ, Warady B, Tang L, Liu J, Li L, Naesens M, Sigdel T, Waskerwitz J, Salvatierra O. Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up. Am J Transplant. 2012 Oct; 12(10):2719-29.
Score: 0.101
-
Bryan CF, Luger AM, Smith JL, Warady BA, Wakefield M, Schadde E, Murillo D, Nelson PW. Sharing kidneys across donor-service area boundaries with sensitized candidates can be influenced by HLA C. Clin Transplant. 2010 Jan-Feb; 24(1):56-61.
Score: 0.085
-
Goldstein SL, Rosburg NM, Warady BA, Seikaly M, McDonald R, Limbers C, Varni JW. Pediatric end stage renal disease health-related quality of life differs by modality: a PedsQL ESRD analysis. Pediatr Nephrol. 2009 Aug; 24(8):1553-60.
Score: 0.081
-
Gillen DL, Stehman-Breen CO, Smith JM, McDonald RA, Warady BA, Brandt JR, Wong CS. Survival advantage of pediatric recipients of a first kidney transplant among children awaiting kidney transplantation. Am J Transplant. 2008 Dec; 8(12):2600-6.
Score: 0.078
-
Toyoda M, Moudgil A, Warady BA, Puliyanda DP, Jordan SC. Clinical significance of peripheral blood Epstein-Barr viral load monitoring using polymerase chain reaction in renal transplant recipients. Pediatr Transplant. 2008 Nov; 12(7):778-84.
Score: 0.075
-
Blowey DL, Warady BA. Outcome of infants born to women with chronic kidney disease. Adv Chronic Kidney Dis. 2007 Apr; 14(2):199-205.
Score: 0.070
-
Bryan CF, Nelson PW, Shield CF, Warady BA, Winklhofer FT, Murillo D, Wakefield MR. Long-term survival of kidneys transplanted from live A2 donors to O and B recipients. Am J Transplant. 2007 May; 7(5):1181-4.
Score: 0.070
-
Warady BA, Chadha V. Chronic kidney disease in children: the global perspective. Pediatr Nephrol. 2007 Dec; 22(12):1999-2009.
Score: 0.070
-
Bryan CF, Wakefield M, Reese JC, Shield CF, Warady BA, Winklhofer FT, Murillo D. Renal graft survival is not influenced by a positive flow B-cell crossmatch. Clin Transplant. 2007 Jan-Feb; 21(1):72-9.
Score: 0.069
-
Bryan CF, McDonald SB, Luger AM, Shield CF, Winklhofer FT, Michael Borkon A, Warady BA, Aeder MI, Murillo D. Successful renal transplantation despite low levels of donor-specific HLA class I antibody without IVIg or plasmapheresis. Clin Transplant. 2006 Sep-Oct; 20(5):563-70.
Score: 0.068
-
Snethen JA, Broome ME, Kelber S, Warady BA. Coping strategies utilized by adolescents with end stage renal disease. Nephrol Nurs J. 2004 Jan-Feb; 31(1):41-9.
Score: 0.056
-
Bryan CF, Cherikh WS, Cheng Y, Aeder MI, Muruve NA, Nelson PW, Shield CF, Warady BA, Winklhofer FT. ABO blood group influences a candidate's likelihood of receiving an HLA zero antigen mismatch kidney. Clin Transplant. 2004; 18 Suppl 12:55-60.
Score: 0.056
-
Bryan CF, Nelson PW, Shield CF, Ross G, Warady B, Murillo D, Winklhofer FT. Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rate. Clin Transpl. 2004; 127-33.
Score: 0.056
-
Warady BA, Ho M. Morbidity and mortality in children with anemia at initiation of dialysis. Pediatr Nephrol. 2003 Oct; 18(10):1055-62.
Score: 0.054
-
Bryan CF, Harrell KM, Mitchell SI, Warady BA, Aeder MI, Luger AM, Murillo D, Muruve NA, Nelson PW, Shield CF. HLA points assigned in cadaveric kidney allocation should be revisited: an analysis of HLA class II molecularly typed patients and donors. Am J Transplant. 2003 Apr; 3(4):459-64.
Score: 0.053
-
Nelson PW, Shield CF, Muruve NA, Murillo D, Warady BA, Aeder MI, Bryan CF. Increased access to transplantation for blood group B cadaveric waiting list candidates by using A2 kidneys: time for a new national system? Am J Transplant. 2002 Jan; 2(1):94-9.
Score: 0.049
-
Muruve NA, Helling TS, Luger AM, Martinez J, Nelson PW, Pierce GE, Ross G, Shield CF, Warady BA, Aeder MI, Bryan CF. Effect of donor brain-death duration on graft outcome. Transplant Proc. 2001 Sep; 33(6):2980-1.
Score: 0.048
-
Stabouli S, Polderman N, Nelms CL, Paglialonga F, Oosterveld MJS, Greenbaum LA, Warady BA, Anderson C, Haffner D, Desloovere A, Qizalbash L, Renken-Terhaerdt J, Tuokkola J, Walle JV, Shaw V, Mitsnefes M, Shroff R. Assessment and management of obesity and metabolic syndrome in children with CKD stages 2-5 on dialysis and after kidney transplantation-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce. Pediatr Nephrol. 2022 01; 37(1):1-20.
Score: 0.048
-
Bryan CF, Luger AM, Martinez J, Muruve N, Nelson PW, Pierce GE, Ross G, Shield CF, Warady BA, Aeder MI, Helling TS. Cold ischemia time: an independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograft. Transplantation. 2001 Apr 15; 71(7):875-9.
Score: 0.047
-
Bryan CF, Martinez J, Muruve N, Nelson PW, Pierce GE, Ross G, Shield CF, Warady BA, Aeder MI, Harrell KM, Helling TS, Luger AM. IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype. Clin Transplant. 2001; 15 Suppl 6:28-35.
Score: 0.046
-
Bryan CF, Shield CF, Pierce GE, Warady BA, Aeder MI, Martinez J, Luger AM, Nelson PW, Ross G, Muruve N, Mitchell SI. Successful cadaveric renal transplantation of patients highly sensitized to HLA Class I antigens. Clin Transplant. 2000 Feb; 14(1):79-84.
Score: 0.043
-
Warady BA, Belden B, Kohaut E. Neurodevelopmental outcome of children initiating peritoneal dialysis in early infancy. Pediatr Nephrol. 1999 Nov; 13(9):759-65.
Score: 0.042
-
Bryan CF, Shield CF, Warady BA, Aeder MI, Helling TS, Luger AM, Martinez J, Nelson PW, Pierce GE, Ross G, Muruve N, Thien ER. Influence of an historically positive crossmatch on cadaveric renal transplantation. Transplant Proc. 1999 Feb-Mar; 31(1-2):225-7.
Score: 0.040
-
Bryan CF, Shield CF, Nelson PW, Pierce GE, Ross G, Luger AM, Warady BA, Helling TS, Aeder MI, Martinez J, Hughes TM, Beck ML, Harrell KM. Transplantation rate of the blood group B waiting list is increased by using A2 and A2B kidneys. Transplantation. 1998 Dec 27; 66(12):1714-7.
Score: 0.040
-
Bryan CF, Baier KA, Nelson PW, Luger AM, Martinez J, Pierce GE, Ross G, Shield CF, Warady BA, Aeder MI, Helling TS, Muruve N. Long-term graft survival is improved in cadaveric renal retransplantation by flow cytometric crossmatching. Transplantation. 1998 Dec 27; 66(12):1827-32.
Score: 0.040
-
Warady B, Watkins SL. Current advances in the therapy of chronic renal failure and end stage renal disease. Semin Nephrol. 1998 May; 18(3):341-54.
Score: 0.038
-
Bryan CF, Mitchell SI, Lin HM, Nelson PW, Shield CF, Luger AM, Pierce GE, Ross G, Warady BA, Aeder MI, Helling TS, Landreneau MD, Harrell KM. Influence of the Rh (D) blood group system on graft survival in renal transplantation. Transplantation. 1998 Feb 27; 65(4):588-92.
Score: 0.037
-
Nelson PW, Landreneau MD, Luger AM, Pierce GE, Ross G, Shield CF, Warady BA, Aeder MI, Helling TS, Hughes TM, Beck ML, Harrell KM, Bryan CF. Ten-year experience in transplantation of A2 kidneys into B and O recipients. Transplantation. 1998 Jan 27; 65(2):256-60.
Score: 0.037
-
Blowey DL, Warady BA. Neonatal outcome in pregnancies associated with renal replacement therapy. Adv Ren Replace Ther. 1998 Jan; 5(1):45-52.
Score: 0.037
-
Warady BA, Fivush B, Morgenstern B. Report of the American Society of Nephrology meeting. J Urol. 1997 May; 157(5):1858-60.
Score: 0.035
-
Portale AA, Wolf MS, Messinger S, Perwad F, J?ppner H, Warady BA, Furth SL, Salusky IB. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children. Clin J Am Soc Nephrol. 2016 11 07; 11(11):1989-1998.
Score: 0.034
-
Luger AM, Bryan CF, O'Brien BJ, Pierce GE, Shield CF, Warady BA, Aeder MI, Landreneau MD, Nelson PW, Ross G. Do African-Americans wait longer for a kidney because of HLA class I antibody specificities and panel-reactive antibody sensitization? Transplant Proc. 1996 Feb; 28(1):157-9.
Score: 0.032
-
Bryan CF, Shield CF, Warady BA, Aeder MI, Landreneau MD, Luger AM, Nelson PW, Pierce GE, Ross G. Allocation of kidneys to Afro-American patients is proportional to wait-list composition. Transplant Proc. 1996 Feb; 28(1):219-20.
Score: 0.032
-
Nelson PW, Hughes TM, Beck ML, Warady BA, Aeder MI, Helling TS, Landreneau MD, Luger AM, Pierce GE, Ross G, et al. Stratification and successful transplantation of patients awaiting ABO-incompatible (A2 into B and O) transplantation by A-isoagglutinin-titer phenogroup. Transplant Proc. 1996 Feb; 28(1):221-3.
Score: 0.032
-
Schwartz ID, Warady BA, Buchanan CL, Reed L, Hussey LM, Howard CP, Hellerstein S, Grunt JA. "Low-dose" growth hormone therapy during peritoneal dialysis or following renal transplantation. Pediatr Nephrol. 1995 Jun; 9(3):320-4.
Score: 0.031
-
Warady BA. Therapeutic camping for children with end-stage renal disease. Pediatr Nephrol. 1994 Jun; 8(3):387-90.
Score: 0.029
-
van Stralen KJ, Borzych-Duzalka D, Hataya H, Kennedy SE, Jager KJ, Verrina E, Inward C, R?nnholm K, Vondrak K, Warady BA, Zurowska AM, Schaefer F, Cochat P. Survival and clinical outcomes of children starting renal replacement therapy in the neonatal period. Kidney Int. 2014 Jul; 86(1):168-74.
Score: 0.028
-
Warady BA, Carr B, Hellerstein S, Alon U. Residential summer camp for children with end-stage renal disease. Child Nephrol Urol. 1992; 12(4):212-5.
Score: 0.024
-
Warady BA, Koch M, O'Neal DW, Higginbotham M, Harris DJ, Hellerstein S. Plasma fluoride concentration in infants receiving long-term peritoneal dialysis. J Pediatr. 1989 Sep; 115(3):436-9.
Score: 0.021
-
Seikaly MG, Salhab N, Warady BA, Stablein D. Use of rhGH in children with chronic kidney disease: lessons from NAPRTCS. Pediatr Nephrol. 2007 Aug; 22(8):1195-204.
Score: 0.018
-
Mahan JD, Warady BA. Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement. Pediatr Nephrol. 2006 Jul; 21(7):917-30.
Score: 0.017
-
Goldstein SL, Graham N, Burwinkle T, Warady B, Farrah R, Varni JW. Health-related quality of life in pediatric patients with ESRD. Pediatr Nephrol. 2006 Jun; 21(6):846-50.
Score: 0.016
-
Gerson AC, Butler R, Moxey-Mims M, Wentz A, Shinnar S, Lande MB, Mendley SR, Warady BA, Furth SL, Hooper SR. Neurocognitive outcomes in children with chronic kidney disease: Current findings and contemporary endeavors. Ment Retard Dev Disabil Res Rev. 2006; 12(3):208-15.
Score: 0.016
-
Lerner GR, Warady BA, Sullivan EK, Alexander SR. Chronic dialysis in children and adolescents. The 1996 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol. 1999 Jun; 13(5):404-17.
Score: 0.010
-
Bryan CF, Harrell KM, Nelson PW, Pierce GE, Ross G, Shield CF, Warady BA, Aeder MI, Helling TS, Landreneau MD, Luger AM. HLA-DR and DQ typing by polymerase chain reaction using sequence-specific primer mixes reduces the incidence of phenotypic homozygosity (blanks) over serology. Transplantation. 1996 Dec 27; 62(12):1819-24.
Score: 0.009
-
Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med. 1996 Apr 04; 334(14):878-83.
Score: 0.008
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|